Data gathered: July 5
Alternative Data for Voyager Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 10 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,871 | Sign up | Sign up | Sign up |
| Twitter Followers | 924 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 52 | Sign up | Sign up | Sign up |
| Linkedin Employees | 177 | Sign up | Sign up | Sign up |
About Voyager Therapeutics
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases.
| Price | $3.20 |
| Target Price | Sign up |
| Volume | 303,240 |
| Market Cap | $177M |
| Year Range | $2.73 - $7.28 |
| Dividend Yield | 0% |
| PE Ratio | 6.02 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Rhumbline Advisers Cuts Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)June 25 - ETF Daily News |
 |
Voyager Therapeutics (NASDAQ:VYGR) and Prime Medicine (NYSE:PRME) Head-To-Head ContrastJune 17 - ETF Daily News |
|
Analysts Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39June 12 - ETF Daily News |
|
Cantor Fitzgerald Weighs in on VYGR FY2026 EarningsJune 11 - ETF Daily News |
|
Squarepoint Ops LLC Sells 32,074 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)June 8 - ETF Daily News |
 |
Voyager Therapeutics: Navigating AAV Headwinds And A Long Road For VY7523 (Downgrade)June 6 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 6.5M | 0 | 0 | -31M | 0 | -0.530 |
| Q4 '24 | 6.3M | 1M | 5.3M | -34M | -37M | -0.590 |
| Q3 '24 | 25M | 0 | 25M | -9M | -13M | -0.160 |
| Q2 '24 | 30M | 34M | -4.9M | -10M | -14M | -0.180 |
| Q1 '24 | 20M | 1.2M | 18M | -11M | -15M | -0.200 |
Insider Transactions View All
| Sandrock Alfred filed to sell 430,931 shares at $3.4. April 4 '25 |
| Ferguson Toby filed to sell 157,914 shares at $3.4. April 4 '25 |
| Swartz Robin filed to sell 98,397 shares at $4.3. February 24 '25 |
| Carter Todd Alfred filed to sell 77,718 shares at $4.3. February 24 '25 |
| Sandrock Alfred filed to sell 296,816 shares at $4.2. February 24 '25 |
Similar companies
Read more about Voyager Therapeutics (VYGR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Voyager Therapeutics?
The Market Cap of Voyager Therapeutics is $177M.
What is Voyager Therapeutics' PE Ratio?
As of today, Voyager Therapeutics' PE (Price to Earnings) ratio is 6.02.
What is the current stock price of Voyager Therapeutics?
Currently, the price of one share of Voyager Therapeutics stock is $3.20.
How can I analyze the VYGR stock price chart for investment decisions?
The VYGR stock price chart above provides a comprehensive visual representation of Voyager Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Voyager Therapeutics shares. Our platform offers an up-to-date VYGR stock price chart, along with technical data analysis and alternative data insights.
Does VYGR offer dividends to its shareholders?
As of our latest update, Voyager Therapeutics (VYGR) does not offer dividends to its shareholders. Investors interested in Voyager Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Voyager Therapeutics?
Some of the similar stocks of Voyager Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.